Robitussin Direct Chest Congestion
- Product NDC
- 0031-9303
- 11-digit product format
- 000319303
- Labeler code
- 0031
- Product ID
- 0031-9303_31fb6502-50db-4216-a202-f5604b1469d4
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- guaifenesin
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-07-15
- Marketing end
- 0000-00-00
- Substance
- GUAIFENESIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0031-9303-01 | 00031930301 | 18 TABLET, COATED in 1 BOTTLE (0031-9303-01) | 2022-07-15 | 0000-00-00 | No | No | Current |